Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager (NIRD-HI)
Key facts
- Who runs it
- The Geneva Foundation
- Where
- San Antonio, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 80 people, planned
- Started
- 1 Jan 2026
- Expected to end
- 29 Sept 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- NIRD-HI scan at the time of enrollment
- Secondary NIRD-HI scan when a planned repeat CT is performed
- Record updated
- 13 January 2026
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- 18 to 89 years of age
- Able to provide written informed consent either by self or legally authorized representative
- Received head CT imaging on admission
- Able to complete at least one NIRD-HI scan within 4 hours of head CT
- Non-operative management planned
Who cannot take part
- Any condition or finding that makes the patient unsuitable for image acquisition in the Investigator's opinion
- Presence of penetrating or non-survivable injuries
- Hemorrhagic shock or large volume transfusion [>3 units of any blood product within; 1 hour of scan]
- Large open skull wounds, scalp lacerations or surface hematomas prohibiting safe or comfortable sensor placement
- Presence of heat tattoos or intracranial metal fixtures
- Cervical injury prolonging C-spine collar
- Known prisoners or wards of state
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Where in United States
- Brooke Army Medical CenterSan Antonio, United StatesContact: Marisol Resendiz, PhDNot yet recruiting
About the trial
What the trial wants to find out
Traumatic Brain Injury (TBI) is a leading cause of death and disability among military personnel, Veterans, and civilians. One of the most dangerous complications of moderate-to-severe TBI is intracranial hemorrhage (ICH). If not identified and treated promptly, ICH can rapidly lead to worsening neurological damage or death. Current diagnostic tools, such as CT scans, are highly effective but impractical for battlefield or resource-limited environments due to their large size and infrastructure dependency.
Read full original descriptionShow less
The Near-Infrared Detection-Head Imaging (NIRD-HI) system is an innovative, noninvasive device using Near-Infrared Spectroscopy (NIRS) to identify abnormal blood accumulation. Unlike traditional tools, NIRD-HI is compact, lightweight, and portable, making it suitable for remote or austere settings. By dynamically imaging the brain, it generates 3D visualizations that pinpoint the size and location of bleeds, including complex bilateral injuries. This offers a significant improvement over current point-of-injury technologies that lack the resolution to reliably diagnose all forms of ICH.
This study supports the FY24 Combat Readiness Medical Research Program by advancing battlefield diagnostic and triage capabilities. The research will:
* Evaluate NIRD-HI's accuracy compared to CT imaging. * Assess feasibility in real-world acute care settings. * Investigate its ability to monitor changes in ICH over time.
These objectives address the military's need for tools that improve rapid diagnosis and decision-making during emergencies. Implementing this research can revolutionize TBI management. For Service Members, NIRD-HI promises a field-ready solution for early detection, enabling faster intervention and more effective triage. By reducing diagnostic delays, it could save lives and prevent long-term complications. Furthermore, the system supports prolonged field care by providing continuous monitoring of evolving injuries.
The benefits extend to civilian healthcare, particularly in rural or underserved areas lacking advanced imaging. This accessibility can improve trauma care outcomes for millions, reduce the burden on healthcare systems, and provide equitable distribution of life-saving technology. By addressing gaps in battlefield medicine, this project aims to enhance medical readiness and improve survivability in the most challenging environments.
The 2 groups in the trial
- 40 participants with positive head bleed on CT report
Subjects with positive head CT reports that may have a diagnosis of TBI or intracranial hemorrhage
Treatment: NIRD-HI scan at the time of enrollment and Secondary NIRD-HI scan when a planned repeat CT is performed
- 40 participants with negative head bleed on CT report
Subjects without positive head CT reports that may have a diagnosis of TBI or intracranial hemorrhage
Treatment: NIRD-HI scan at the time of enrollment and Secondary NIRD-HI scan when a planned repeat CT is performed
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager for Detection of Intracranial Hemorrhage in the Acute Care Setting
- Criteria questions
- Built from NCT07338383, who can take part
- Record updated
- 13 January 2026